EMEA (Europe, Middle East and Africa) Intravenous-to-Subcutaneous Drug Market Report 2017

December 2017 | 104 pages | ID: E7B0573E9D0EN
QYResearch

Abstracts

In this report, the EMEA Intravenous-to-Subcutaneous Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Intravenous-to-Subcutaneous Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Intravenous-to-Subcutaneous Drug market competition by top manufacturers/players, with Intravenous-to-Subcutaneous Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• GSK
• Merck

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Prescription
• OCT

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Intravenous-to-Subcutaneous Drug Market Report 2017

1 INTRAVENOUS-TO-SUBCUTANEOUS DRUG OVERVIEW

1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
1.2 Classification of Intravenous-to-Subcutaneous Drug
  1.2.1 EMEA Intravenous-to-Subcutaneous Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Intravenous-to-Subcutaneous Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Prescription
  1.2.4 OCT
1.3 EMEA Intravenous-to-Subcutaneous Drug Market by Application/End Users
  1.3.1 EMEA Intravenous-to-Subcutaneous Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 EMEA Intravenous-to-Subcutaneous Drug Market by Region
  1.4.1 EMEA Intravenous-to-Subcutaneous Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drug (2012-2022)
  1.5.1 EMEA Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)

2 EMEA INTRAVENOUS-TO-SUBCUTANEOUS DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Intravenous-to-Subcutaneous Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Intravenous-to-Subcutaneous Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Intravenous-to-Subcutaneous Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Intravenous-to-Subcutaneous Drug Sale Price by Players (2012-2017)
2.2 EMEA Intravenous-to-Subcutaneous Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Intravenous-to-Subcutaneous Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Intravenous-to-Subcutaneous Drug Sale Price by Type (2012-2017)
2.3 EMEA Intravenous-to-Subcutaneous Drug (Volume) by Application
2.4 EMEA Intravenous-to-Subcutaneous Drug (Volume and Value) by Region
  2.4.1 EMEA Intravenous-to-Subcutaneous Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Intravenous-to-Subcutaneous Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Intravenous-to-Subcutaneous Drug Sales Price by Region (2012-2017)

3 EUROPE INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  3.1.1 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
3.3 Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
3.4 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Intravenous-to-Subcutaneous Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Intravenous-to-Subcutaneous Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  4.1.1 Middle East Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
4.3 Middle East Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
4.4 Middle East Intravenous-to-Subcutaneous Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Intravenous-to-Subcutaneous Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Intravenous-to-Subcutaneous Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)

5 AFRICA INTRAVENOUS-TO-SUBCUTANEOUS DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
  5.1.1 Africa Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
5.3 Africa Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
5.4 Africa Intravenous-to-Subcutaneous Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Intravenous-to-Subcutaneous Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Intravenous-to-Subcutaneous Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)

6 EMEA INTRAVENOUS-TO-SUBCUTANEOUS DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 INTRAVENOUS-TO-SUBCUTANEOUS DRUG MANUFACTURING COST ANALYSIS

7.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INTRAVENOUS-TO-SUBCUTANEOUS DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Intravenous-to-Subcutaneous Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Intravenous-to-Subcutaneous Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Intravenous-to-Subcutaneous Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Intravenous-to-Subcutaneous Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Intravenous-to-Subcutaneous Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Intravenous-to-Subcutaneous Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Intravenous-to-Subcutaneous Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Intravenous-to-Subcutaneous Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Intravenous-to-Subcutaneous Drug
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Prescription Product Picture
Figure OCT Product Picture
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Intravenous-to-Subcutaneous Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure EMEA Intravenous-to-Subcutaneous Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Intravenous-to-Subcutaneous Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales Share by Players (2012-2017)
Figure 2016 Intravenous-to-Subcutaneous Drug Sales Share by Players
Figure 2017 Intravenous-to-Subcutaneous Drug Sales Share by Players
Figure EMEA Intravenous-to-Subcutaneous Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Intravenous-to-Subcutaneous Drug Revenue Share by Players
Table 2017 EMEA Intravenous-to-Subcutaneous Drug Revenue Share by Players
Table EMEA Intravenous-to-Subcutaneous Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share by Type (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Type in 2016
Table EMEA Intravenous-to-Subcutaneous Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Application (2012-2017)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share by Application in 2016
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Region (2012-2017)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share in 2016
Table EMEA Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Region (2012-2017)
Figure EMEA Intravenous-to-Subcutaneous Drug Revenue Market Share Regions in 2016
Table EMEA Intravenous-to-Subcutaneous Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Market Share by Type (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Market Share by Type in 2016
Table Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Market Share by Application (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Market Share by Application in 2016
Table Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Market Share by Countries (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Market Share by Countries (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Market Share by Countries in 2016
Table Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries in 2016
Figure Germany Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Market Share by Type (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Market Share by Type (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Market Share by Applications (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Sales Market Share by Application in 2016
Table Middle East Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Sales Volume Market Share by Countries in 2016
Table Middle East Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Type (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Type (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Type in 2016
Table Africa Intravenous-to-Subcutaneous Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Application (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Application (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Countries (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Countries (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share by Countries in 2016
Table Africa Intravenous-to-Subcutaneous Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Intravenous-to-Subcutaneous Drug Revenue Market Share by Countries in 2016
Figure South Africa Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Novartis Intravenous-to-Subcutaneous Drug Basic Information List
Table Novartis Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Intravenous-to-Subcutaneous Drug Sales Market Share in EMEA (2012-2017)
Figure Novartis Intravenous-to-Subcutaneous Drug Revenue Market Share in EMEA (2012-2017)
Table GSK Intravenous-to-Subcutaneous Drug Basic Information List
Table GSK Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GSK Intravenous-to-Subcutaneous Drug Sales Market Share in EMEA (2012-2017)
Figure GSK Intravenous-to-Subcutaneous Drug Revenue Market Share in EMEA (2012-2017)
Table Merck Intravenous-to-Subcutaneous Drug Basic Information List
Table Merck Intravenous-to-Subcutaneous Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Intravenous-to-Subcutaneous Drug Sales Market Share in EMEA (2012-2017)
Figure Merck Intravenous-to-Subcutaneous Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous-to-Subcutaneous Drug
Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
Figure Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
Table Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
Table Major Buyers of Intravenous-to-Subcutaneous Drug
Table Distributors/Traders List
Figure EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Intravenous-to-Subcutaneous Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Intravenous-to-Subcutaneous Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Intravenous-to-Subcutaneous Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Intravenous-to-Subcutaneous Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources